Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool July 6, 2005 Stephen D. Simpson	No Blues From This Delta Underfollowed and underappreciated, Delta & Pine Land is an interesting agribiotech play.
The Motley Fool March 2, 2005 Brian Gorman	Monsanto's Brazil Benefit Brazil is on the cusp of legalizing genetically modified seed sales, a potential boon for Monsanto.
The Motley Fool April 6, 2005 W.D. Crotty	Fast-Blooming Biotech Monsanto's net sales and net income soar in the second quarter. Is it time to buy this stock?
The Motley Fool February 18, 2005 Brian Gorman	Monsanto Cottons to Emergent Monsanto's second acquisition in less than a month signals an aggressive move into cotton seeds. Investors will no doubt keep a close eye on this one.
The Motley Fool July 6, 2006 Stephen D. Simpson	Delta and Pine Land Grows on Investors A strong quarter sends the stock of the seed company to a 52-week high.
The Motley Fool August 15, 2006 Stephen D. Simpson	Second Time the Charm? Eight years after an ill-fated initial merger attempt, Monsanto is once again trying to buy cottonseed specialist Delta and Pine Land in an all-cash $1.5 billion proposed merger. Investors, take note.
The Motley Fool July 30, 2004 Brian Gorman	In China, Hope for Modified Seeds China leans toward allowing genetically modified crops, a potential windfall for Monsanto and competitors.
The Motley Fool January 3, 2007 Emil Lee	Delta & Pine Land Continues The Dance with Monsanto Can this couple get together? Given the uncertainty surrounding the merger, arbitrageurs may wish to dabble in Delta's stock.
The Motley Fool January 6, 2006 Stephen D. Simpson	Investors Don't Cotton to Delta Cotton-seed producers Delta and Pine Land's first quarter is usually sleepy, but investors still found reasons to sell.
The Motley Fool December 6, 2005 Brian Gorman	Monsanto's Trade Dividend The giant and competitors in agricultural biotechnology should enjoy rising sales in the developed world as subsidies come down. Investors, take note.
Registered Rep. April 1, 2006 Bob Hirschfeld	Good Breeding Ag-biotech is entering a period of vibrant growth as farmers, not only in the U.S., but Brazil, India and China increase usage of the highly productive seeds. Is Wall Street valuing shares of ag-biotech companies correctly?
The Motley Fool January 4, 2007 Brian Gorman	Monsanto's Bigger Harvest? High corn prices could allow Monsanto to raise seed prices and improve margins. Investors, take note.
The Motley Fool April 4, 2006 Stephen D. Simpson	The Look and Feel of Delta & Pine's Cotton Delayed shipments hurt this quarter, but increased acreage estimates are good news for the cottonseed specialist. Investors: buy, sell or hold?
The Motley Fool February 24, 2006 Brian Gorman	Syngenta's Potential Harvest The agricultural technology outfit is developing a seed with lots of potential. Syngenta remains under the radar for most investors, but if the company presses ahead with its GM wheat project, it's not likely to stay that way for long.
The Motley Fool December 5, 2006 Brian Gorman	Monsanto Needs to Charm The company has to confront concerns over genetically modified foods soon if it hopes to keep growing. Investors, take note.
The Motley Fool October 10, 2007 Billy Fisher	Monsanto's Monster Year There's no doubt that 2007 has been a monster year for Monsanto, due to the craze over ethanol and corn, but will it last looking forward?
The Motley Fool April 13, 2006 Brian Gorman	Monsanto's New Challenge The ag-biotech firm faces new competitive pressures from rivals and an ongoing wariness of GM crops in Europe.
The Motley Fool August 6, 2009 Brian Orelli	No More Flower Power for Monsanto Monsanto sells its sunflower business to rival Syngenta for $160 million.
The Motley Fool April 3, 2006 Rich Smith	Foolish Forecast: Delta & Pine Land When considering this farming company's margin trends, it's best for investors to focus on rolling gross and operating margins and be leery of drawing conclusions from the net results.
The Motley Fool September 28, 2005 Brian Gorman	Monsanto's Rich Pipeline The agrochemical giant's long-term health looks assured thanks to a rich product pipeline. Investors, take note.
The Motley Fool May 19, 2004 Brian Gorman	U.N. Plants Seed for Agribusiness Its endorsement of biotech foods could clear the way for agribusiness in the developing world.
BusinessWeek January 21, 2010 Jack Kaskey	Monsanto Will Let Bio-Crop Patents Expire Genetically engineered soybeans will go generic, but woe to anyone that crosses the seed giant on new products.
The Motley Fool June 28, 2006 Brian Gorman	Monsanto's Stealth Buys Several small acquisitions should keep profits buoyant as demand for corn rises. Investors, take note.
The Motley Fool April 5, 2006 Stephen D. Simpson	This GM Actually Works Monsanto's path may be strewn with weeds, but rewards could still lurk within. This is a good company, and looks to be undervalued by a mid-teens percentage. Investors, take note.
The Motley Fool March 29, 2005 Stephen D. Simpson	Monsanto Sows the Seeds of Growth The agricultural specialist hikes earnings guidance on the back of strong sales. The present valuation may look rich, but investors shouldn't underestimate this growing titan.
The Motley Fool June 26, 2008 Brian Orelli	Why Throw Tomatoes at Monsanto? There wasn't a lot to complain about in Monsanto's third-quarter earnings report, but investors found enough disappointing news to send the stock down.
The Motley Fool January 2, 2007 Rich Duprey	Foolish Forecast: Monsanto Blooms What will crop up in the agricultural behemoth's first-quarter 2007 earnings?
BusinessWeek April 29, 2010 Kaskey & Ligi	The Seed Makers Who Don't Pray for Rain Agricultural companies tweak crops to flourish with less.
The Motley Fool March 31, 2004 W.D. Crotty	Monsanto in the Balance Genetically modified crops are a boon for the company.
BusinessWeek July 14, 2003 Arlene Weintraub	The Outcry over "Terminator" Genes in Food Critics fear such safeguards present fresh genetic perils
The Motley Fool May 25, 2011 Neha Chamaria	When Will Cotton Finally Settle Down? High cotton prices are eating into apparel companies' bottom lines.
The Motley Fool June 22, 2004 Brian Gorman	More Green for Monsanto The full-year earnings the agribusiness giant Monsanto may not please everyone, but the company plants roots for long-term success.
The Motley Fool April 2, 2008 Rich Duprey	The Short Case for Origin Agritech Origin Agritech manufacturers genetically modified corn, rice, cotton, and canola seeds in China. Much can go right for this company, but, much can also go wrong.
The Motley Fool July 17, 2007 Brian Orelli	A Fruitful Collaboration Monsanto and BASF team up to grow better plants. Long-term investors should take it as a sign that Monsanto and BASF are putting their capital to good use.
The Motley Fool January 6, 2010 Brian Orelli	Monsanto Needs to Round Up Some Growth Monsanto announces a $0.03 first-quarter loss compared with $1.00 per share of income a year ago. That's not exactly starting the year off on the right foot.
The Motley Fool December 5, 2008 Brian Orelli	Monsanto Ready to Round Up Growth The company announces that the European Union has approved its genetically modified soybean seeds for import.
Chemistry World July 22, 2013 Phillip Broadwith	Monsanto abandons GM crops in Europe The company will focus on conventional breeding to develop new crop varieties in the EU, and develop biotech crops in regions where they are more accepted, such as North America.
The Motley Fool June 26, 2007 Rich Duprey	Foolish Forecast: Monsanto's Monstrous Growth Agricultural products company Monsanto will report third-quarter 2007 financial results on Thursday. Will investors on the sidelines be green with envy?
AskMen.com Dustin Driver	Genetically Modified Foods Before you make any snap judgments, take the time to learn what Genetically Modified Organisms (GMOs) are.
Reason January 2001 Ronald Bailey	Dr. Strangelunch Or: Why we should learn to stop worrying and love genetically modified food...
The Motley Fool January 4, 2008 Brian Orelli	Monsanto Rounds Up Growth Sales grew 36% year-over-year at Monsanto; since sales growth significantly outpaced costs, the bottom line looked even better, with diluted EPS nearly tripling.
The Motley Fool December 6, 2011 Neha Chamaria	Debugging Monsanto's Bug Concerns Doubts about Monsanto's pest-resistant seeds' efficiency grow. Should you become cautious?
Nutrition Action Healthletter June 2000 Michael F. Jacobson	News From CSPI Critics and advocates of crops that are engineered to carry genes from other species are waging a battle royal. The public will hotly debate biotechnology for years to come. Our goal should be to throw out any dirty bathwater, but not the baby.
The Motley Fool April 24, 2006 Alyce Lomax	The Genetically Modified Conundrum What's in your food? Some companies don't want you to know. GM foods are bolstering the profits of companies like Monsanto, and there are some logical reasons why anti-GM advocates suspect a level of foul play.
The Motley Fool September 3, 2008 Brian Orelli	Monsanto's Public-Relations Nightmare Agriculture giant Monsanto has to defend its patents without looking like it's picking on the little guy.
The Motley Fool July 18, 2011 Jacob Roche	Don't Buy In to Cotton's Head Fake Cotton prices are falling, but expect retailers to continue struggling.
The Motley Fool March 23, 2006 Alyce Lomax	Monsanto: Monster Stock, or Just Plain Monster? Many things seem to be going right for Monsanto. However, what price are you willing to pay for growth? Are the profits worth the risks -- and the possible long-term ramifications -- for both investors and consumers?
AskMen.com Sebastien Stefanov	Are Modified Foods Dangerous? What foods are potentially dangerous, what are the risks and how can consumers protect themselves against this new industry?
The Motley Fool January 11, 2012 Jacob Roche	Betting the Farm on Monsanto The biotech giant sits at the top of the food chain.
The Motley Fool October 13, 2005 Brian Gorman	Monsanto's Abundant Harvest The agricultural technology giant's strong 2005 results demonstrate that business is on track. As for the future, the company now expects fiscal 2006 earnings to be between $2.35 and $2.50 per share, up from a June prediction of $2.34.